Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1999 1
2000 1
2001 3
2002 2
2003 1
2004 1
2006 2
2008 2
2009 8
2010 4
2011 2
2012 2
2013 2
2014 8
2015 9
2016 8
2017 3
2018 6
2019 3
2020 5
2021 10
2022 8
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Identification and Analysis of Monoclonal Antibodies with Neutralizing Activity against Diverse SARS-CoV-2 Variants.
Ishimaru H, Nishimura M, Tjan LH, Sutandhio S, Marini MI, Effendi GB, Shigematsu H, Kato K, Hasegawa N, Aoki K, Kurahashi Y, Furukawa K, Shinohara M, Nakamura T, Arii J, Nagano T, Nakamura S, Sano S, Iwata S, Okamura S, Mori Y. Ishimaru H, et al. Among authors: arii j. J Virol. 2023 Jun 29;97(6):e0028623. doi: 10.1128/jvi.00286-23. Epub 2023 May 16. J Virol. 2023. PMID: 37191569 Free PMC article.
Fourth mRNA vaccination increases cross-neutralizing antibody titers against SARS-CoV-2 variants, including BQ.1.1 and XBB, in a very elderly population.
Sutandhio S, Furukawa K, Kurahashi Y, Marini MI, Effendi GB, Hasegawa N, Ishimaru H, Nishimura M, Arii J, Mori Y. Sutandhio S, et al. Among authors: arii j. J Infect Public Health. 2023 Jul;16(7):1064-1072. doi: 10.1016/j.jiph.2023.05.004. Epub 2023 May 6. J Infect Public Health. 2023. PMID: 37196370 Free PMC article.
The Neutralizing Antibody Response against Severe Acute Respiratory Syndrome Coronavirus 2 and the Cytokine/Chemokine Release in Patients with Different Levels of Coronavirus Diseases 2019 Severity: Cytokine Storm Still Persists Despite Viral Disappearance in Critical Patients.
Tjan LH, Nagano T, Furukawa K, Nishimura M, Arii J, Fujinaka S, Iwata S, Sano S, Tohma Y, Nishimura Y, Mori Y. Tjan LH, et al. Among authors: arii j. JMA J. 2021 Jan 29;4(1):1-7. doi: 10.31662/jmaj.2020-0083. Epub 2021 Jan 14. JMA J. 2021. PMID: 33575497 Free PMC article. Review.
Cross-Neutralizing Breadth and Longevity Against SARS-CoV-2 Variants After Infections.
Kurahashi Y, Sutandhio S, Furukawa K, Tjan LH, Iwata S, Sano S, Tohma Y, Ohkita H, Nakamura S, Nishimura M, Arii J, Kiriu T, Yamamoto M, Nagano T, Nishimura Y, Mori Y. Kurahashi Y, et al. Among authors: arii j. Front Immunol. 2022 Feb 24;13:773652. doi: 10.3389/fimmu.2022.773652. eCollection 2022. Front Immunol. 2022. PMID: 35281007 Free PMC article.
Combating herpesvirus encephalitis by potentiating a TLR3-mTORC2 axis.
Sato R, Kato A, Chimura T, Saitoh SI, Shibata T, Murakami Y, Fukui R, Liu K, Zhang Y, Arii J, Sun-Wada GH, Wada Y, Ikenoue T, Barber GN, Manabe T, Kawaguchi Y, Miyake K. Sato R, et al. Among authors: arii j. Nat Immunol. 2018 Oct;19(10):1071-1082. doi: 10.1038/s41590-018-0203-2. Epub 2018 Sep 10. Nat Immunol. 2018. PMID: 30201994
86 results